en
lv
ru
Investors
Corporate Governance
Financial Calendar
Financial News
Presentations
Documents
Analysts
Shareholders’ Meetings
Investor contacts
Media
Latest News
Photo Library
Media Contacts
Sponsorship and support
Careers
Personnel Policy
Vacancies
Application Form
Internship
Career Contacts
Contacts
Training courses and actual information
Search
Home
Company
About Olainfarm
Business Strategy
Governance and Management
Board
Supervisory Council
Senior Executive Team
Auditing Committee
Olainfarm Worldwide
Responsibility
Video surveillance privacy statement
Licences and Certificates
Quality Policy
Environment Protection Policy
Participation in Projects
Ongoing projects
Completed projects
Procurements
Awards
History
Articles of Association
In memoriam
Products and Services
Products
Over the Counter (OTC)
Prescription Medicines
Food Supplements
APIs and Intermediates
APIs
Intermediates
Pharmacovigilance
Services
QC/QA Services
Regulatory Services
APIs and Intermediates Development
Final Dosage Forms Development
Contract Manufacturing
Research and Development
R&D of APIs and Intermediates
R&D of Final Dosage Forms
Preclinical Trials
Clinical Trials
Cooperation
Investors
MAJOR SHAREHOLDERS
Shareholding 31 December 2019
Investors
07.25.2015
Investors
Documents
Information on Shares
Dividends
Analysts
Corporate Governance
Financial Calendar
Financial News
Investor Contacts
Presentations
Shareholders’ Meetings
Search
Recent Posts
JSC Olainfarm donates funds to the Children’s Hospital Foundation for the purchase of new mattresses
January 14, 2021
Olainfarm medicines reach patients in Russia according to new medication verification regulations
December 12, 2020
Olainfarm Group maintains its profit forecast, a short term decline in 9 month sales results
December 2, 2020
JSC Olainfarm donates funds to the National reference laboratory of Riga East Hospital for the purchase of Covid-19 analysis equipment
November 23, 2020
“Olainfarm” confirmed the compliance with Russian Good Manufacturing Practice (GMP)
November 2, 2020
